Despite nearly two years of internal restructuring, WHO’s budget at its Geneva headquarters is still twice the amount spent in all 54 countries of the Organization’s African Region, said the African bloc of stated at Wednesday’s World Health Assembly.  Speaking on behalf of the African bloc, Seychelles noted that the most recent WHO financial report […] Continue reading ->
The World Health Assembly on Tuesday approved a resolution calling to strengthen WHO and global preparedness for health emergencies – with few new teeth but lots of symbolism attached. The resolution makes a sweeping, but still largely ceremonial, call to countries and the WHO to reinvigorate systems of emergency preparedness, vulnerability assessment,  alert, response, compliance […] Continue reading ->
This year’s 73rd edition of the World Health Assembly resumes virtually on Monday, after a two-day emergency huddle in May – against sharply rising COVID-19 infection rates in Europe and the United States, deep geopolitical divides – and calls for reform of the WHO that could strengthen its mandate but also may be resisted by […] Continue reading ->
IBADAN, Nigeria – In the wake of George Floyd’s death in June 2020, the decentralized protests initially organized by the Black Lives Matter (BLM) movement triggered an awakening and an echo that has reached well beyond the borders of the United States. What started as a non-violent movement protesting against incidents of police brutality and […] Continue reading ->
As predictions of a difficult winter pour in, projecting rapid increases in COVID-19 infections, the World Health Organisation (WHO) has urged countries in the northern hemisphere to test for influenza alongside coronavirus. WHO reassrerted today that surveillance systems are in place to help identify which influenza viruses are circulating, and suggested that countries be proactive […] Continue reading ->
Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern.  The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading ->